PharmiWeb.com
Dear Colleague,
Welcome to the latest update from PharmiWeb.com
  eyeforpharmas 2nd Annual Generics Marketing & Sales Summit
eyeforpharmas 2nd Annual Generics Marketing & Sales Summit, May 16-17th, Berlin
 
Gain action-oriented solutions on how to execute your marketing & sales initiatives to guarantee improved market share for your drugs.
 
You will get exclusive insights on:
  • Differential promotional strategies for successful market impact
  • How to use price to optimise sales of your drugs
  • Future of generics marketing and sales to stay ahead of the market trends
  • Powerful marketing campaigns to increase your competitiveness against branded pharma
  • Benchmarking methods to evaluate the success of your marketing initiatives
  • Key essentials for a targeted and quick launch of your drugs
  • Blueprints for maximising your CRM capabilities

Learn from an expert line up of speakers from the top generics organisations including: Teva, Ivax, Glenmark Pharma, Pliva, Ratiopharm, Betapharm, Stada, AESEG and many more.

PLUS! eyeforpharma guarantee: 20 expert speakers dynamic workshops 2 days of unparalleled networking 20 in-depth sessions focusing exclusively on the hot issues in the generics industry
 
Dont forget to take advantage of this Special Offer quote Pharmiweb to get a 30% discount! Visit http://www.eyeforpharma.com/generics2006/pw to download the full brochure NOW!
Read More
Featured Jobs
General Manager (milan Office)Milano, ItalyExellent Benefits
Recruitment ConsultantBracknellExcellent Benefits Package
Marketing Project ManagerBracknell Berkshire, UKHighly Competitive Salary and benefits
More
Latest PharmiWeb.com Statistics

JOBS: Search through 5551 live job vacancies on PharmiWeb.com right now

Quicklinks
Latest Sales and Marketing Jobs
Latest Clinical Research Jobs
Current Executive Jobs (£100K PA)
Bird Flu In-Detail
Search For Pharma Business Opportunities
Field Reporters Needed
PharmiWeb.com Today Stories
09/03Pfizer eyes generic biologics market
08/03Early sign of artery damage found
07/03NHS chief executive to stand down
06/03Key genes for sight defect found
02/03Drug 'blocks Alzheimer's course'
More PharmiWeb.com Today Stories
PharmiWeb.com Features
Antibodies are the first wave of IGF-1R antagonists for cancer therapy
- La Merie Business Intelligence (06/03/2006)
Big Challenges For Pharma
- Ed Bowsher (06/03/2006)
Rituxan approval to mark a new era of B-cell targeted therapies of autoimmune disease?
- LeadDiscovery (01/03/2006)
An Interview with Andrew Copestake Vice President - BD Europe
- Mike Wood (28/02/2006)
Abbott - Planning to Win
- Caroline Johnson (24/02/2006)
More PharmiWeb.com Features
Featured Events
13 Mar...4th Annual Sales Force Effectiveness Summit EuropeCCIB, Barcelona
31 MarIntroduction To Clinical Trials - PharmaTower Mains Ltd, 18E, L...
24 AprDemystifying Pharmaceutical FinanceVenue: The Rembrandt Hote...
More PharmiWeb.com Events
Press Releases
Fast Track Program Firmly Established In U.s., Acc
- Tufts Center for the Study of Drug Development (08/03/2006)
Man Fined For The Illegal Internet Sale And Supply
- MHRA (08/03/2006)
Exelon Granted Eu Marketing Authorization As First Treatment For Dementia Associated With Parkinsons Disease By European Commission
- Novartis (08/03/2006)
Sirocom - Just The Tonic For Unichem
- UniChem Ltd (08/03/2006)
Abilify (aripiprazole) In A Naturalistic Study Demonstrates Significantly Superior Effectiveness
- Bristol-Myers Squibb (08/03/2006)
More Press Releases

Best Regards

Mike Wood ...and the team at PharmiWeb.com
To ensure that your PharmiWeb e-mails get to your inbox, please add mike@pharmiweb.com to your e-mail Address Book or Safe List.
PharmiWeb.com is a product of PharmiWeb Solutions.
Providing Collaborative Portals, Mobile Solutions and Web Solutions across Healthcare.
For editorial enquiries regarding this newsletter or the website, please contact editor@pharmiWeb.com , call: +44 (0) 1344 667448
.

Please note: we are not responsible for content that is external to our site, submitted to us by our contributors or outside our direct control.